Z. Guo et al. / Tetrahedron: Asymmetry 42 (2001) 571–577
575
3.5.4. Enzyme purification step 4: UNO-Q1 column. The
3.7. Chemical syntheses of ( )-3a to 3f
enzyme solution from step 3 was concentrated (50 kDa
cut off membrane) to 2 mL and loaded on to an
UNO-Q1 ion exchange column (Bio-Rad, 1 mL). The
column was eluted with buffer A (5 mL) followed by a
gradient elution with increasing buffer H (0.8 M NaCl
in buffer A) from 0 to 60% in 20 mL. The fractions
with high specific activity were pooled (2 mL).
The synthesis of ( )-3a was completed as reported
previously.8 ( )-3b to 3f were synthesised similarly
using the following general procedure. To a stirred
solution of trimethylsilyl cyanide (20 mmol, 1984 mg,
2667 mL) in CH2Cl2 (80 mL) at 0°C, the aldehyde 2 (20
mmol) was added, followed by TEA (2 mmol, 202 mg,
278 mL). The resulting mixture was stirred at 0°C for 2
h and the solvent was removed under reduced pressure.
The residue was dissolved in anhydrous ether (20 mL)
and added to a stirred solution of benzylmagnesium
chloride (20 mL, 1.0 M in ether). The reaction mixture
was stirred under reflux for 2 h and then cooled to
room temperature. Water (20 mL) was added with
caution followed by HCl (4 M, 20 mL) with vigorous
stirring. The progress of the reaction was followed by
TLC. After completion of hydrolysis, the product was
extracted with ethyl acetate (2×40 mL). The extract was
washed successively with water, 5% sodium bicarbon-
ate, water, 1 M HCl, water, and brine, then dried over
MgSO4 and concentrated to dryness.
3.5.5. Enzyme purification step 5: Superdex 200 column.
The pooled fractions from step 4 were concentrated by
ultrafiltration (50 kDa cut off membrane) to 0.2 mL
and loaded onto a Superdex 200 column (Pharmacia,
24 mL) previously equilibrated with buffer A. The
column was eluted with buffer A. The fractions with
high specific activity were combined (2 mL).
3.5.6. Enzyme purification step 6: ISO column. The
pooled fractions from step 5 were adjusted to 1 M
concentration of (NH4)2SO4, loaded onto an ISO
hydrophobic interaction column (Pharmacia, 1 mL)
previously equilibrated with buffer D. The column was
eluted with 5 mL of buffer D followed by gradient
elution from buffer D to buffer A in 10 mL. An activity
assay was performed after (NH4)2SO4 was removed
from each fraction (50 kDa cut off membrane). The
fractions with highest specific activity were pooled (2
mL).
Flash chromatography on silica and elution with
CH2Cl2 gave oily products 3b (1.54 g, 43%); 3c (2.27 g,
59%); 3d (2.14 g, 52%); and 3e (1.62 g, 34%). For 3f,
elution with CH2Cl2–MTBE (19:1) gave a solid, which
was recrystallised from hexane–MTBE (2:1) to afford 3f
(0.43 g, 10%). The results of HPLC analyses are shown
in Section 3.2.
3.5.7. Determination of molecular weight. Gel filtration
column (Superdex 200, Pharmacia, 24 mL) was cali-
brated with standard proteins (Gel filtration chro-
matography standard, Bio-Rad) and eluted with buffer
G (0.2 M NaCl in buffer A). The elution parameter
kav=(Ve−Vo)/(Vt−Vo) was used for the preparation of
calibration curve, where Ve=elution volume for the
protein, Vo=column void volume, and Vt=total bed
volume.11
1
3.7.1. 3-Hydroxy-1-phenyl-2-pentanone 3b. H NMR l
0.92 (t, 3H), 1.64 (m, 1H), 1.95 (m, 1H), 3.34 (m, 1H),
3.76 (d, 1H), 3.79 (d, 1H), 4.25 (m, 1H), 7.1–7.4 (m,
5H); (CDCl3–2% D2O): l 0.92 (t, J=7.3, 3H), 1.64 (m,
1H), 1.93 (m, 1H), 3.76 (d, J=15.6, 1H), 3.79 (d,
J=15.6, 1H), 4.25 (m, 1H), 7.1–7.4 (m, 5H). LCMS
(ES+) m/z 179 (M+H).
1
3.7.2. 3-Hydroxy-1-phenyl-2-hexanone 3c1. H NMR l
0.95 (t, 3H), 1.30–1.75 (m, 3H), 1.90 (m, 1H), 3.32 (d,
1H, D2O exchangeable), 3.75 (d, 1H), 3.84 (d, 1H), 4.32
(m, 1H), 7.1–7.4 (m, 5H). LCMS (ES+) m/z 193 (M+
H).
3.6. Immobilisation of the enzyme and acyloin conden-
sation with the immobilised enzyme
DE52 resin (10 mL bed volume) was equilibrated with
buffer A and added to the crude cell extract of A.
eurydice (20 mL). The mixture was shaken at 20 rpm
for 20 h and then filtered. The adsorbed resins were
washed with buffer A (5×30 mL) and suspended in the
same buffer to give a final volume of 30 mL. One
fourth of the suspension was used to catalyse the
acyloin condensation of 1 with 2a in 14 reaction cycles.
For each cycle, a mixture of the immobilised enzyme,
MgCl2 (120 mL, 100 mM), TPP (80 mL, 50 mM), 1 (200
mL, 100 mM), 2a (200 mL, 1 M), and buffer A (to adjust
the final volume to 10 mL) was shaken at 50 rpm, 28°C
for 20 h and then filtered. The resins were washed with
buffer A (3×10 mL) and then used in the next reaction
cycle. The combined filtrate and washes were acidified
with HCl (1 M, 2 mL) and extracted with MTBE (2×15
mL). The extract was evaporated to dryness. The
residue was dissolved in CH3CN (2 mL) and analysed
by HPLC method 1.
1
3.7.3. 3-Hydroxy-1-phenyl-2-heptanone 3d. H NMR l
0.90 (t, J=7.3, 3H), 1.25–1.48 (m, 4H), 1.58 (m, 1H),
1.88 (m, 1H), 3.38 (brs, 1H), 3.76 (d, J=15.1, 1H), 3.80
(d, J=15.1, 1H), 4.27 (m, 1H), 7.15–7.38 (m, 5H).
LCMS (ES+) m/z 207 (M+H).
1
3.7.4. 3-Hydroxy-1,4-diphenyl-2-butanone 3e. H NMR
l 2.89 (dd, J1=14.2, J2=7.3, 1H), 3.17 (dd, J1=14.2,
J2=4.9, 1H), 3.25 (d, J=5.8, 1H, D2O exchangeable),
3.75 (d, J=15.6, 1H), 3.81 (d, J=15.6, 1H), 4.50 (m,
1H), 7.14–7.38 (m, 10H). LCMS (ES+) m/z 258 (M+
NH4).
1
3.7.5. 1-Hydroxy-1,3-diphenyl acetone 3f. H NMR l
3.62 (d, J=16.1, 1H), 3.66 (d, J=16.1, 1H), 4.24 (d,
J=4.2, 1H, D2O exchangeable), 5.19 (d, J=4.2, 1H; s